dexmedetomidine has been researched along with Cardiac Rupture, Traumatic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, A; Li, Y; Lin, J; Wang, C; Xia, Z; Yang, CF; Yuan, W; Zhang, Z | 1 |
| Chen, X; Chi, X; Liao, M; Luo, A; Yang, H; Yang, L; Zhao, Y | 1 |
| Liu, GP; Sun, C; Xue, FS; Yang, GZ | 1 |
| Hutchens, MP; Thorborg, P | 1 |
1 trial(s) available for dexmedetomidine and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
Dexmedetomidine Attenuates Myocardial Injury in Off-Pump Coronary Artery Bypass Graft Surgery.
Topics: Biomarkers; Coronary Artery Bypass, Off-Pump; Dexmedetomidine; Drug Therapy, Combination; Female; Heart Injuries; Humans; Male; Methyl Ethers; Middle Aged; Postoperative Complications; Prospective Studies; Sevoflurane; Troponin I | 2016 |
3 other study(ies) available for dexmedetomidine and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
Dexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Ferroptosis; Heart; Heart Injuries; Male; Mice, Inbred C57BL; Myocardium; Sepsis | 2020 |
Use of Dexmedetomidine to Attenuate Myocardial Injury After Off-Pump Coronary Artery Bypass Grafting Surgery.
Topics: Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Dexmedetomidine; Heart Injuries; Humans; Treatment Outcome | 2017 |
Dexmedetomidine sedation (and cardiac perforation, pericardial tamponade, cardiac arrest, and cardiopulmonary resuscitation) leading to refractory cardiogenic shock.
Topics: Cardiac Tamponade; Cardiopulmonary Resuscitation; Dexmedetomidine; Heart Arrest; Heart Injuries; Humans; Hypnotics and Sedatives; Risk Factors; Shock, Cardiogenic; Vasoconstrictor Agents | 2009 |